1205Lu Human metastatic melanoma cells, not human!

Journal of Cancer Science and Therapy

Volumn 5, Issue 3, 2013, Pages 119-

  Nair, Hareesh B ^a   Bhaskaran, Shylesh ^a   Pathak, Sen ^b   Ghosh, Rita ^c   Betty, Dunn ^d   Moore, Charleen M ^c   VandeBerg, John L ^a  

^a SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4;

CHROMOSOME ANALYSIS; GENE MUTATION; HUMAN; KARYOTYPING; LETTER; MELANOMA CELL; METASTATIC MELANOMA; NONHUMAN;

EID: 84875346821     PISSN: None     EISSN: 19485956     Source Type: Journal    
DOI: 10.4172/1948-5956.1000196     Document Type: Letter

References (5)

1. Smalley KS, Lioni M, Dalla Palma M, Xiao M, Desai B, et al. (2008) Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600Emutated melanomas. Mol Cancer Ther 7: 2876-2883.
2. Gembarska A, Luciani F, Fedele C, Russell EA, Dewaele M, et al. (2012) MDM4 is a key therapeutic target in cutaneous melanoma. Nat Med. doi:10.1038/ nm.2863
3. Tsai J, Lee JT, Wang W, Zhang J, Cho H, et al. (2008) Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity. Proc Natl Acad Sci USA 105: 3041-3046.
4. Höglund M, Gisselsson D, Hansen GB, White VA, Säll T, et al. (2004) Dissecting karyotypic patterns in malignant melanomas: temporal clustering of losses and gains in melanoma karyotypic evolution. Int J Cancer. 108: 57-65.
5. Pathak S (1976) Chromosome banding techniques. J Reprod Med 17: 25-28.